close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

Strona główna・Stock List・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Closed

SectorHealthcare

29.38 2.69

Strong Buy

Price update 20 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

28.56

Max

29.8

Key metrics

By Trading Economics

Income

66M

-35M

Sales

70M

71M

Profit margin

-49.028

Employees

143

EBITDA

66M

-34M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+38.53% upside

Market Stats

By TradingEconomics

Market Cap

613M

2.8B

Previous open

26.69

Previous close

29.38

News Sentiment

By Acuity

50%

50%

182 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

12 / 13.14 Support & Resistance

VIRIDIAN THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 lis 2025, 23:07 UTC

Market Talk

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

DJ

Read

20 lis 2025, 22:22 UTC

Market Talk

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

DJ

Read

20 lis 2025, 22:08 UTC

Market Talk

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

DJ

Read

20 lis 2025, 21:57 UTC

Earnings

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

DJ

Read

20 lis 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

20 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

20 lis 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

DJ

Read

20 lis 2025, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

DJ

Read

20 lis 2025, 21:31 UTC

Earnings

Nvidia's Strong Results Show AI Fears Are Premature -- Update

DJ

Read

20 lis 2025, 21:23 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

DJ

Read

20 lis 2025, 21:07 UTC

Earnings

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

DJ

Read

20 lis 2025, 21:06 UTC

Earnings

Webull 3Q Rev $156.9M >BULL

DJ

Read

20 lis 2025, 21:06 UTC

Earnings

Webull 3Q EPS 7c >BULL

DJ

Read

20 lis 2025, 21:05 UTC

Earnings

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

DJ

Read

20 lis 2025, 21:04 UTC

Earnings

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

DJ

Read

20 lis 2025, 21:04 UTC

Earnings

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

DJ

Read

20 lis 2025, 21:04 UTC

Earnings

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Backs FY26 Rev $21B-$21.19B >INTU

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit 1Q Consumer Rev $894M

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Backs FY26 Guidance

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

DJ

Read

20 lis 2025, 21:00 UTC

Earnings

Intuit 1Q Global Business Solutions Rev $3B

DJ

Read

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

38.53% upside

12 Months Forecast

Average 39.73 USD  38.53%

High 61 USD

Low 14.017 USD

Based on 13 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Based on 13 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

12 / 13.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

182 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,041.67

↓-0.67%

JNJ

Johnson and Johnson

203.38

↑ +0.19%

ABBV

AbbVie Inc

229.55

↓-1.49%

UNH

UnitedHealth Group Inc

311.75

↑ +0.84%

AZN

AstraZeneca PLC ADR

88.67

↓-0.36%
help-icon Live chat